ABOUT THIS EVENT
AbCellera Biologics Inc. (Nasdaq: ABCL), a technology company that aims to become the centralized operating system for next-generation antibody discovery, rings the Nasdaq Closing Bell remotely from across the country.
Carl Hansen, Ph.D., Director & CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.